360 related articles for article (PubMed ID: 34680774)
1. Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review.
Trama F; Illiano E; Marchesi A; Brancorsini S; Crocetto F; Pandolfo SD; Zucchi A; Costantini E
Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680774
[TBL] [Abstract][Full Text] [Related]
2. Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis.
Kuo HC
Low Urin Tract Symptoms; 2023 Nov; 15(6):210-215. PubMed ID: 37702275
[TBL] [Abstract][Full Text] [Related]
3. Improved Urothelial Cell Proliferation, Cytoskeleton and Barrier Function Protein Expression in the Patients With Interstitial Cystitis/Bladder Pain Syndrome After Intravesical Platelet-Rich Plasma Injection.
Jhang JF; Jiang YH; Hsu YH; Ho HC; Birder LA; Lin TY; Kuo HC
Int Neurourol J; 2022 Feb; 26(Suppl 1):S57-67. PubMed ID: 35073671
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency.
Ke QS; Jhang JF; Lin TY; Ho HC; Jiang YH; Hsu YH; Kuo HC
Ci Ji Yi Xue Za Zhi; 2019; 31(3):135-143. PubMed ID: 31258287
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
Jhang JF; Yu WR; Kuo HC
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
[TBL] [Abstract][Full Text] [Related]
6. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study.
Jhang JF; Wu SY; Lin TY; Kuo HC
Low Urin Tract Symptoms; 2019 Apr; 11(2):O42-O47. PubMed ID: 29265766
[TBL] [Abstract][Full Text] [Related]
7. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
Jhang JF; Lin TY; Kuo HC
Neurourol Urodyn; 2019 Feb; 38(2):703-709. PubMed ID: 30576011
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma.
Lee YK; Jiang YH; Jhang JF; Ho HC; Kuo HC
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625918
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Efficacy of Intravesical Platelet-Rich Plasma Injections for Interstitial Cystitis/Bladder Pain Syndrome-A Comparative Study of Different Injection Number, Additives and Concentrations.
Jiang YH; Jhang JF; Lin TY; Ho HC; Hsu YH; Kuo HC
Front Pharmacol; 2022; 13():853776. PubMed ID: 35392571
[No Abstract] [Full Text] [Related]
10. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis.
Jiang YH; Kuo YC; Jhang JF; Lee CL; Hsu YH; Ho HC; Kuo HC
Sci Rep; 2020 Sep; 10(1):15218. PubMed ID: 32939046
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
12. The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection.
Jhang JF; Jiang YH; Lin TY; Kuo HC
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203334
[TBL] [Abstract][Full Text] [Related]
13. A Novel Intravesical Dextrose Injection Improves Lower Urinary Tract Symptoms on Interstitial Cystitis/Bladder Pain Syndrome.
Chen CL; Kao CC; Yang MH; Fan GY; Cherng JH; Tsao CW; Wu ST; Cha TL; Meng E
Front Pharmacol; 2021; 12():755615. PubMed ID: 34975473
[TBL] [Abstract][Full Text] [Related]
14. Early three-month report of amniotic bladder therapy in patients with interstitial cystitis/bladder pain syndrome.
Madan R; Radoiu C; Liaw A; Lucas S; Hamada A; Dhar N
Int Urol Nephrol; 2023 Aug; 55(8):1937-1942. PubMed ID: 37273012
[TBL] [Abstract][Full Text] [Related]
15. New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome - Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave.
Lin CC; Huang YC; Lee WC; Chuang YC
Int Neurourol J; 2020 Sep; 24(3):211-221. PubMed ID: 33017892
[TBL] [Abstract][Full Text] [Related]
16. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
[TBL] [Abstract][Full Text] [Related]
17. Platelet-Rich Plasma Ameliorates Cyclophosphamide-Induced Acute Interstitial Cystitis/Painful Bladder Syndrome in a Rat Model.
Chen YH; Man KM; Chen WC; Liu PL; Tsai KS; Tsai MY; Wu YT; Chen HY
Diagnostics (Basel); 2020 Jun; 10(6):. PubMed ID: 32521683
[TBL] [Abstract][Full Text] [Related]
18. Secondary Analysis of Interstitial Cystitis/Bladder Pain Syndrome Patients Enrolled in a Recurrent Urinary Tract Infection Prevention Study Provides a Novel Paradigm for Etio-Pathogenesis and Practical Management of This Infection Phenotype.
Nickel JC; Cotechini T; Doiron RC
Pathogens; 2024 May; 13(5):. PubMed ID: 38787248
[TBL] [Abstract][Full Text] [Related]
19. Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).
Chuang YC; Chermansky C; Kashyap M; Tyagi P
Expert Opin Investig Drugs; 2016; 25(5):521-9. PubMed ID: 26940379
[TBL] [Abstract][Full Text] [Related]
20. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
Dellis A; Papatsoris AG
Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
